A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2001
11/29/2001	WO2001042471A8 Polypeptides and polynucleotides encoding same
11/29/2001	WO2001042445A3 USE OF RECOMBINANT PARAINFLUENZA VIRUSES (PIVs) AS VECTORS TO PROTECT AGAINST INFECTION AND DISEASE CAUSED BY PIV AND OTHER HUMAN PATHOGENS
11/29/2001	WO2001040451A3 Masp-3, a complement-fixing enzyme, and uses for it
11/29/2001	WO2001040309A3 Anti-prostate stem cell antigen (psca) antibody compositions and methods of use
11/29/2001	WO2001038566A3 Screening method for candidate drugs
11/29/2001	WO2001031007A3 Nucleic acid molecules derived from rat brain and programmed cell death models
11/29/2001	WO2001029064A8 Melanoma antigens and methods of use
11/29/2001	WO2001028583A3 Melanoma vaccine and methods of making and using same
11/29/2001	WO2001025433A3 Novel polypeptides, their nucleic acids, and methods for their use in angiogenesis and vascularization
11/29/2001	WO2001023560A3 Isolated peptides which bind to mhc class ii molecules, and uses thereof
11/29/2001	WO2001017550A3 Vaccine against hbv and hpv
11/29/2001	WO2001000864A3 Nucleic acid binding of multi-zinc finger transcription factors
11/29/2001	WO2000056298A9 Treatment of lyme disease with polysulfated glycosaminoglycan formulations
11/29/2001	WO2000053229A3 Protein conjugates on the basis of lumazine synthase, methods for producing them and the use thereof
11/29/2001	WO2000047104A9 Antagonists of hmg1 for treating inflammatory conditions
11/29/2001	WO2000045792A8 Hydrogel particle formulations
11/29/2001	WO2000040722A3 Insulin-synthesis genes
11/29/2001	US20010047090 VANILREP1 polynucleotides and VANILREP1 polypeptides
11/29/2001	US20010047083 Produced by hybridoma cell line ATCC No. HB12003 and progeny thereof; used in detection or treatment of carcinoembryonic antigen associated tumors
11/29/2001	US20010047080 Inhibits hiv infection of cells
11/29/2001	US20010046976 Antimicrobial histone h1 compositions, kits, and methods of use thereof
11/29/2001	US20010046967 Methods of preventing and treating respiratory viral infection using immunomodulatory polynucleotide
11/29/2001	US20010046959 Method of treating cancer with anti-neurotrophin agents
11/29/2001	US20010046955 Administering an agent that increases the biological activity of a calcitonin gene related peptide receptor in the lungs, such as a corticosteroid, beta-agonist, leukotriene inhibitor, antihistamine or phosphodiesterase inhibitor
11/29/2001	US20010046522 Herbal supplement for cognitive related impairment due to estrogen loss
11/29/2001	US20010046501 Administering a tumor or infectious agent specific antigen followed by administration of a superantigen at an optimized time interval following adminstration of tumor or infection agent specific antigen to maximize cellular immune response
11/29/2001	US20010046500 Administering a vaccine in ovo to a fertile egg containing an embryo of the chicken and wherein the vaccine comprises an immunogenically effective amount of a live, avirulent strain of infectious bronchitis virus to treat infectious bronchitis
11/29/2001	US20010046499 Tick antigens and compositions and methods comprising them
11/29/2001	US20010046496 Administering to the human having a disease associated with leukocyte infiltration of mucosal tissues a humanized immunoglobulin or antigen-binding fragment having binidng specificity for alpha 4 beta 7 integrain
11/29/2001	US20010046490 Cell surface molecule-induced macrophage activation
11/29/2001	US20010046489 Stem cells of the islets of langerhans and their use in treating diabetes mellitus
11/29/2001	US20010046483 Medicaments for manipulating T-cell immune response
11/29/2001	US20010045465 Bar code scanner with collimated scan volume
11/29/2001	DE10024383A1 Mit toxischen Substanzen beladene dendritische Zellen With toxic substances loaded dendritic cells
11/29/2001	CA2808215A1 Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
11/29/2001	CA2410563A1 Methods for preventing strokes by inducing tolerance to e-selectin
11/29/2001	CA2410520A1 Mutated eukariotic translation initiation factor 2 alpha kinase 3, eif2ak3, in patients with neonatal insulin-dependent diabetes and multiple epiphyseal dysplasia (wolcott-rallison syndrome)
11/29/2001	CA2410293A1 Three-layer parenteral preparations
11/29/2001	CA2410096A1 Card domain containing polypeptides, encoding nucleic acids, and methods of use
11/29/2001	CA2409874A1 Porcine reproductive and respiratory syndrome virus (prrsv) recombinant avipoxvirus vaccine
11/29/2001	CA2409873A1 Hcv variants
11/29/2001	CA2409299A1 Compositions and methods for the therapy and diagnosis of breast cancer
11/29/2001	CA2408925A1 Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid beta for induction of an immune response to amyloid beta and amyloid deposits
11/29/2001	CA2408883A1 Methods for diagnosing and treating hemostatic disorders by modulating p-selectin activity
11/29/2001	CA2408743A1 Method of detecting inflammatory lung disorders
11/29/2001	CA2408739A1 Novel proteins and nucleic acids encoding same, diagnostic and therapeutic uses
11/29/2001	CA2408315A1 Aminoacyl trna synthetases
11/28/2001	EP1158050A1 Human cysteinyl leukotriene receptor (CysLT2)
11/28/2001	EP1158004A2 Human monoclonal antibody against a costimulatory signal transduction molecule AILIM and pharmaceutical use thereof
11/28/2001	EP1158003A1 Antibodies capable to selectively detect prion PrP Sc isoforms
11/28/2001	EP1158002A1 Human G-protein coupled receptor
11/28/2001	EP1157275A1 Novel transduction molecules and methods for using same
11/28/2001	EP1157123A1 Stable recombinant influenza viruses free of helper viruses
11/28/2001	EP1157121A1 Prrsv vaccines
11/28/2001	EP1157113A1 Haemophilus antigen
11/28/2001	EP1157111A1 Angiopoietin-related protein and nucleic acids
11/28/2001	EP1157094A2 Method for the purification, recovery, and sporulation of cysts and oocysts
11/28/2001	EP1157043A1 Anti-gpr-9-6 and anti-teck antibodies and methods of identifying modulators of gpr-9-6 and teck functions
11/28/2001	EP1157042A1 Production of tetravalent antibodies
11/28/2001	EP1157041A2 Antibodies for cancer therapy and diagnosis
11/28/2001	EP1157036A1 Immunomodulating glycopeptide
11/28/2001	EP1157035A1 Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof
11/28/2001	EP1157033A1 Synthetic peptides containing protective epitopes for the treatment and prevention of periodontitis associated with porphyromonas gingivalis
11/28/2001	EP1156824A2 Compositions and methods for treating cancer and hyperproliferative disorders
11/28/2001	EP1156823A1 Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies
11/28/2001	EP1156820A1 Vascular endothelial growth factor-2
11/28/2001	EP1156819A1 Methods and compositions for modulating fertility
11/28/2001	EP1156811A2 Copper agonist that binds on the copper binding site of app and/or exerts an inhibiting effect on the release of amyloid a beta peptide
11/28/2001	EP1156717A1 A recombinant polypeptide for use in the manufacture of vaccines against campylobacter induced diarrhea and to reduce colonization
11/28/2001	EP0845032B1 Isolated nucleic acid molecules, peptides which form complexes with mhc molecule hla-a2 and uses thereof
11/28/2001	EP0783520B1 Broadly reactive opsonic antibodies reactive with common staphylococcal antigens
11/28/2001	EP0698108B1 Adenoviral vectors of animal origin and use thereof in gene therapy
11/28/2001	CN1324406A DNA molecules encoding MUC-1 and use thereof in tumor vaccination
11/28/2001	CN1324405A Novel G protein-coupled receptor proteins, DNAS thereof and ligands to the same
11/28/2001	CN1324403A PRV-1 gene and the use thereof
11/28/2001	CN1324374A Biodegradable low molecular weight triblock polyester polyethylene glocol copolymers having reverse thermal gelation properties
11/28/2001	CN1324258A Aglyco products and method of use
11/28/2001	CN1324245A Activation and protection of T-cells (CD4+ and CD8+) using and H2 receptor agonist and other T-cell activating agents
11/28/2001	CN1324243A Method for treating inflammatory inflammatory diseases using heat shock proteins
11/28/2001	CN1324212A Method for treating or preventing viral infections and associated diseases
11/28/2001	CN1075387C Antitumor agent potentiator comprising IL-6 antagonist
11/27/2001	US6323336 PhoH homolog
11/27/2001	US6323322 Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof
11/27/2001	US6323027 Common gamma chain monoclonal antibody blocking agents
11/27/2001	US6323024 Plasmids for the expression of heterologus genes; for use in treatment and prevention of viral diseases
11/27/2001	US6323020 Neutralization-sensitive epitopes of Cryptosporidium parvum
11/27/2001	US6323005 Transferrin-binding protein 1 (TBP1) gene of Actinobacillus pleuropneumoniae, its use to prepare products for the utilization in vaccines for pleuropneumonia and as diagnostic reagents
11/27/2001	US6322999 Cloned genes coding for human receptors, and cell lines expressing genes, in order to generate a proper screen for human therapeutic compounds
11/27/2001	US6322967 Recombinant tryptophan mutants of influenza
11/27/2001	US6322964 Synthetic HIV-2 gag and env oligopeptides reactive with HIV-2 specific antibodies
11/27/2001	US6322809 Containing one or more bacteria entrapped in liposome
11/27/2001	US6322804 Implantable biocompatible immunoisolatory vehicle for the delivery of selected therapeutic products
11/27/2001	US6322796 Immunological tolerance-inducing agent
11/27/2001	US6322795 Papilloma viruses, agents for detecting them and for treating diseases caused by such viruses
11/27/2001	US6322794 Seroreactive epitopes on proteins of human papillomavirus (HPV) 18
11/27/2001	US6322793 Replacement of gene 50 glycoprotein with foreign genetic material
11/27/2001	US6322790 Treatment of primary and metastatic noeplastic diseases and infectious diseases; administering antigen presenting cells sensitized with complexes of hsps noncovalently bound to an antigenic molecule
11/27/2001	US6322789 Peptide form an epitope-major histocompatibility complex recognized by a cytotoxic t cell and is linked to a lipid; formulated as vaccines; used in diagnostic methods
11/27/2001	US6322787 Induction of an anti-tumor immunity by redirecting tumor cells against antigen-presenting cells
11/27/2001	US6322780 Marek's disease virus vaccines for protection against Marek's disease

1 ... 1378 1379 1380 1381 1382 1383 1384 1385 1386 1387 1388 1389 1390 1391 1392 1393 1394 1395 1396 1397 1398 ... 1823